HIGHLIGHTS
- who: Lubaba Shahrin et al. from the International Centre for Diarrhoeal Disease Research, Bangladesh (icddr, b), Dhaka, Bangladesh have published the research: Intravenous Amoxicillin Plus Intravenous Gentamicin for Children with Severe Pneumonia in Bangladesh: An Open-Label, Randomized, Non-Inferiority Controlled Trial, in the Journal: Life 2021, 11, 1299. of 31/Oct/2019
- what: In the setting , the primary reason for choosing IV amoxicillin over ampicillin is the cost, which is four times less as per market value in the study site, Bangladesh. Should the trial be successful, amoxicillin can be implemented in similar settings . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.